Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Seock‐Ah Im | Researchclopedia

Back to researchers

Seock‐Ah Im

Seoul National University ORCID

1,134

Works

68,579

Citations

98

h-index

519

i10-index

Research Topics

Advanced Breast Cancer Therapies HER2/EGFR in Cancer Research Breast Cancer Treatment Studies

Affiliations

AstraZeneca (United Kingdom)2012–2012

Ulsan College2017–2024

University of Southern California2011–2011

Roche (Switzerland)2011–2023

Seoul National University of Science and Technology2010–2010

Top Works

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

Peter Schmid,Sylvia Adams,et al.

20184,270 citations

Cancer Treatment and Pharmacology

PARP inhibition in cancer therapy

Olaparib for Metastatic Breast Cancer in Patients with a Germline <i>BRCA</i> Mutation

Mark E. Robson,Seock‐Ah Im,et al.

20173,129 citations

Palbociclib and Letrozole in Advanced Breast Cancer

Richard S. Finn,Miguel Martín,et al.

20162,882 citations

Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer

José Baselga,Javier Cortés,et al.

20112,496 citations

Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer

Shanu Modi,William Jacot,et al.

20222,403 citations

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial

Luca Gianni,Tadeusz Pieńkowski,et al.

20112,316 citations

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

Shanu Modi,Cristina Saura,et al.

20191,889 citations

Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy

Norikazu Masuda,Soo-Jung Lee,et al.

20171,844 citations

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

Massimo Cristofanilli,Nicholas C. Turner,et al.

20161,799 citations